Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
In the last 90 days, Protara Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Protara Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- −1 vs. Q4 2024
- Shares held
- 28.8M
- −910.3K (−3.1%) vs. Q4 2024
- Total value
- $123.8M
- −$32.8M (−21.0%) vs. Q4 2024
- New holders
- 8
- 24 more added
- Sold out
- 9
- 12 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 3,788,176 | $17.4M | 0.01% | +1,516,344+66.7% | Added |
| Ra Capital Management, L.P. | 3,400,000 | $14.5M | 0.24% | 00.0% | Unchanged |
| Blackstone Group Inc. | 1,744,042 | $7.43M | 0.03% | +64,042+3.8% | Added |
| Opaleye Management Inc. | 1,730,000 | $7.37M | 1.64% | −95,000−5.2% | Reduced |
| Velan Capital Investment Management LP | 1,667,800 | $7.10M | 7.31% | +88,800+5.6% | Added |
| Vanguard Group Inc | 1,602,852 | $6.83M | 0.00% | +243,343+17.9% | Added |
| Sio Capital Management, LLC | 1,514,300 | $6.45M | 1.95% | +76,800+5.3% | Added |
| Integral Health Asset Management, LLC | 1,400,000 | $5.96M | 0.66% | 00.0% | Unchanged |
| Acorn Capital Advisors, LLC | 1,279,800 | $5.45M | 3.64% | 00.0% | Unchanged |
| StemPoint Capital LP | 1,190,579 | $5.07M | 1.62% | +858,185+258.2% | Added |
| Catalio Capital Management, LP | 1,088,691 | $4.64M | 1.15% | 00.0% | Unchanged |
| Woodline Partners LP | 851,674 | $3.63M | 0.02% | −1,486−0.2% | Reduced |
| 5AM Venture Management, LLC | 800,000 | $3.41M | 1.29% | 00.0% | Unchanged |
| UBS Group AG | 636,674 | $2.71M | 0.00% | +487,266+326.1% | Added |
| BlackRock, Inc. | 630,459 | $2.69M | 0.00% | +514,422+443.3% | Added |
| Millennium Management LLC | 568,421 | $2.42M | 0.00% | +196,968+53.0% | Added |
| Baker Bros. Advisors LP | 536,832 | $2.29M | 0.03% | 00.0% | Unchanged |
| Citadel Advisors LLC | 412,531 | $1.76M | 0.00% | −615,003−59.9% | Reduced |
| Superstring Capital Management LP | 360,000 | $1.53M | 1.83% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 346,697 | $1.48M | 0.00% | +167,104+93.0% | Added |
| Bank of America Corp | 288,717 | $1.23M | 0.00% | +94,320+48.5% | Added |
| Susquehanna International Group, LLP | 274,881 | $1.17M | 0.00% | +56,408+25.8% | Added |
| Driehaus Capital Management LLC | 272,342 | $1.16M | 0.01% | −244,810−47.3% | Reduced |
| CIBC World Markets Inc. | 235,610 | $1.00M | 0.00% | +235,610 | New |
| Walleye Capital LLC | 229,454 | $977.5K | 0.01% | +8,640+3.9% | Added |
| Goldman Sachs Group Inc | 199,254 | $848.8K | 0.00% | −3,971−2.0% | Reduced |
| Oppenheimer & Co Inc | 186,564 | $794.8K | 0.01% | −14,862−7.4% | Reduced |
| BNP Paribas Arbitrage, SA | 151,906 | $647.1K | 0.00% | 00.0% | Unchanged |
| J. Goldman & Co LP | 146,341 | $623.4K | 0.02% | +4,593+3.2% | Added |
| Renaissance Technologies LLC | 129,400 | $551.2K | 0.00% | −12,900−9.1% | Reduced |
| ADAR1 Capital Management, LLC | 122,690 | $522.7K | 0.10% | 00.0% | Unchanged |
| Barclays PLC | 93,239 | $397.2K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 91,455 | $389.6K | 0.00% | +53,721+142.4% | Added |
| State Street Corp | 83,200 | $354.4K | 0.00% | +1,000+1.2% | Added |
| Omers Administration Corp | 75,100 | $319.9K | 0.00% | +75,100 | New |
| Northern Trust Corp | 72,175 | $307.5K | 0.00% | +43,462+151.4% | Added |
| Dimensional Fund Advisors LP | 69,603 | $297.2K | 0.00% | +48,606+231.5% | Added |
| Morgan Stanley | 66,215 | $282.1K | 0.00% | −33,312−33.5% | Reduced |
| Qube Research & Technologies Ltd | 61,917 | $263.8K | 0.00% | +61,917 | New |
| Gsa Capital Partners LLP | 54,857 | $234.0K | 0.02% | +19,310+54.3% | Added |
| Truist Financial Corp | 40,000 | $170.4K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 40,000 | $170.4K | 0.00% | +15,000+60.0% | Added |
| American Century Companies Inc | 36,249 | $154.4K | 0.00% | +36,249 | New |
| Bailard, Inc. | 29,769 | $126.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 23,590 | $100.5K | 0.00% | +9,957+73.0% | Added |
| LPL Financial LLC | 23,000 | $98.0K | 0.00% | −13,000−36.1% | Reduced |
| Jain Global LLC | 19,212 | $81.8K | 0.00% | +19,212 | New |
| Balyasny Asset Management LLC | 18,710 | $79.7K | 0.00% | +18,710 | New |
| Bank of New York Mellon Corp | 18,350 | $78.2K | 0.00% | +2,467+15.5% | Added |
| Charles Schwab Investment Management Inc | 15,000 | $63.9K | 0.00% | +15,000 | New |
| Squarepoint Ops LLC | 12,232 | $52.1K | 0.00% | −8,523−41.1% | Reduced |
| Quantessence Capital LLC | 10,188 | $43.4K | 0.01% | +10,188 | New |
| Commonwealth Equity Services, LLC | 10,000 | $43.0K | 0.00% | −27,000−73.0% | Reduced |
| Citigroup Inc | 3,639 | $15.5K | 0.00% | −9,306−71.9% | Reduced |
| Royal Bank of Canada | 3,500 | $15.0K | 0.00% | 00.0% | Unchanged |
| Semmax Financial Advisors Inc. | 1,572 | $5.09K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 147 | $626 | 0.00% | +30+25.6% | Added |
| SBI Securities Co., Ltd. | 143 | $609 | 0.00% | +40+38.8% | Added |
| Advisor Group Holdings, Inc. | 100 | $426 | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −2,250,000−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −2,088,937−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −350,489−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −88,941−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −62,429−100.0% | Sold out |
| HBK Investments L P | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −11,740−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,394−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −30−100.0% | Sold out |